MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/16Accenture plc(ACN)10/16TRAVELERS COMPANIES, INC.(TRV)10/15MARSH & MCLENNAN COMPANIES, INC.(MRSH)10/13DOMINOS PIZZA INC(DPZ)10/9MICRON TECHNOLOGY INC(MU)10/9DELTA AIR LINES, INC.(DAL)10/8PEPSICO INC(PEP)10/8LEVI STRAUSS & CO(LEVI)10/8CONSTELLATION BRANDS, INC.(STZ)10/8CINTAS CORP(CTAS)10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/16Accenture plc(ACN)10/16TRAVELERS COMPANIES, INC.(TRV)10/15MARSH & MCLENNAN COMPANIES, INC.(MRSH)10/13DOMINOS PIZZA INC(DPZ)10/9MICRON TECHNOLOGY INC(MU)10/9DELTA AIR LINES, INC.(DAL)10/8PEPSICO INC(PEP)10/8LEVI STRAUSS & CO(LEVI)10/8CONSTELLATION BRANDS, INC.(STZ)10/8CINTAS CORP(CTAS)10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$1,918K
Net Income
-$6,479K
Net Profit Margin
-337.80%
EPS
-$2.62
Unit: Thousand (K) dollars
Income Statement
2026-06-30
Collaboration revenue
1,918
Research and development
8,823
General and administrative
2,490
Total operating expenses
11,313
Loss from operations
-9,395
Interest income and other income (expense), net
383
Interest expense
276
Change in fair value of convertible note
3,023
Net loss before provision for income taxes
-6,265
(provision for)/ benefit from income tax
212
Net loss
-6,477
Net unrealized loss on available-for-sale investments
-2
Net comprehensive loss
-6,479
Basic EPS
-2.62
Diluted EPS
-2.62
Basic Average Shares
2,475,898
Diluted Average Shares
2,475,898
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

SCTX Income Statement Sankey DiagramSankey diagram visualizing SCTX income statement for the periodNet comprehensiveloss-$6,479K Net loss-$6,477K Net unrealized losson...-$2K Net loss beforeprovision for income taxes-$6,265K (provision for)/ benefitfrom income tax$212K Change in fair value ofconvertible note$3,023K Interest income and otherincome (expense), net$383K Loss from operations-$9,395K Collaboration revenue$1,918K Interest expense$276K Total operatingexpenses$11,313K Research and development$8,823K General andadministrative$2,490K

Scribe Therapeutics, Inc. (SCTX)

Scribe Therapeutics, Inc. (SCTX)